These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26874281)

  • 61. Beyond proof of concepts for ideal cardiac regenerative therapy.
    Mochizuki N; Pearson JT; Kitamura S
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):964-965. PubMed ID: 28645824
    [No Abstract]   [Full Text] [Related]  

  • 62. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of mesenchymal stem cell-derived cytokines on the functional properties of endothelial progenitor cells.
    Kamprom W; Kheolamai P; U-Pratya Y; Supokawej A; Wattanapanitch M; Laowtammathron C; Issaragrisil S
    Eur J Cell Biol; 2016; 95(3-5):153-63. PubMed ID: 26899034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic transdifferentiation of human fibroblasts into endothelial cells using forced expression of lineage-specific transcription factors.
    Wong WT; Cooke JP
    J Tissue Eng; 2016; 7():2041731416628329. PubMed ID: 27081470
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling.
    Zhou H; Zhang R; Li M; Wang F; Gao Y; Fang K; Zong J; Chang X
    J Immunol Res; 2024; 2024():5009637. PubMed ID: 39081633
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human vascular organoids with a mosaic
    He S; Zhu Y; Chauhan S; Tavakol DN; Lee JH; Berris RB; Xu C; Lee JH; Lee C; Cai S; McElroy S; Vunjak-Novakovic G; Tomer R; Azizi E; Xu B; Lao YH; Leong KW
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328122
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiovascular Tissue Engineering Models for Atherosclerosis Treatment Development.
    Tscheuschner L; Tzafriri AR
    Bioengineering (Basel); 2023 Nov; 10(12):. PubMed ID: 38135964
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling.
    Whitworth CP; Polacheck WJ
    Expert Opin Drug Discov; 2024 Mar; 19(3):339-351. PubMed ID: 38117223
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system.
    Lee JH; Shores KL; Breithaupt JJ; Lee CS; Fodera DM; Kwon JB; Ettyreddy AR; Myers KM; Evison BJ; Suchowerska AK; Gersbach CA; Leong KW; Truskey GA
    APL Bioeng; 2023 Dec; 7(4):046103. PubMed ID: 37854060
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new approach of using organ-on-a-chip and fluid-structure interaction modeling to investigate biomechanical characteristics in tissue-engineered blood vessels.
    Wang L; Chen Z; Xu Z; Yang Y; Wang Y; Zhu J; Guo X; Tang D; Gu Z
    Front Physiol; 2023; 14():1210826. PubMed ID: 37275235
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Updated Perspectives on Direct Vascular Cellular Reprogramming and Their Potential Applications in Tissue Engineered Vascular Grafts.
    Sellahewa SG; Li JY; Xiao Q
    J Funct Biomater; 2022 Dec; 14(1):. PubMed ID: 36662068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent advances in regenerative biomaterials.
    Cao D; Ding J
    Regen Biomater; 2022; 9():rbac098. PubMed ID: 36518879
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PBPK Modeling on Organs-on-Chips: An Overview of Recent Advancements.
    Yang Y; Chen Y; Wang L; Xu S; Fang G; Guo X; Chen Z; Gu Z
    Front Bioeng Biotechnol; 2022; 10():900481. PubMed ID: 35497341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Atypical Expression of Smooth Muscle Markers and Co-activators and Their Regulation in Rheumatic Aortic and Calcified Bicuspid Valves.
    Latif N; Sarathchandra P; McCormack A; Yacoub MH; Chester AH
    Front Cardiovasc Med; 2022; 9():793666. PubMed ID: 35369286
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System.
    Zhang X; Abutaleb NO; Salmon E; Truskey GA
    Methods Mol Biol; 2022; 2375():77-90. PubMed ID: 34591300
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biofabrication of tissue engineering vascular systems.
    Zhang Q; Bosch-Rué È; Pérez RA; Truskey GA
    APL Bioeng; 2021 Jun; 5(2):021507. PubMed ID: 33981941
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emulating Early Atherosclerosis in a Vascular Microphysiological System Using Branched Tissue-Engineered Blood Vessels.
    Lee JH; Chen Z; He S; Zhou J; Tsai A; Truskey G; Leong KW
    Adv Biol (Weinh); 2021 Apr; 5(4):e2000428. PubMed ID: 33852179
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vascular Microphysiological Systems to Model Diseases.
    Zhang Q; Zhang X; Truskey GA
    Cell Gene Ther Insights; 2020; 6(1):93-102. PubMed ID: 32431950
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.
    Horisawa K; Suzuki A
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(4):131-158. PubMed ID: 32281550
    [TBL] [Abstract][Full Text] [Related]  

  • 80. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
    Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
    Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.